Abstract
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CAP), are diffcult to propagate, and can cause clinically indistinguish able disease patterns. During 2011-2012, we used molecu lar methods to test adult patients in Germany with confrmed CAP for infection with these 2 pathogens. Overall, 12.3% (96/783) of samples were positive for M. pneumoniae and 3.9% (31/794) were positive for Chlamydia spp.; C. psittaci (2.1%) was detected more frequently than C. pneumoniae (1.4%). M. pneumoniae P1 type 1 predominated, and lev els of macrolide resistance were low (3.1%). Quarterly rates of M. pneumoniae-positive samples ranged from 1.5% to 27.3%, showing a strong epidemic peakforthese infections, but of Chlamydia spp. detection was consistent throughout the year. M. pneumoniae-positive patients were younger and more frequently female, had fewer co-occurring condi tions, and experienced milder disease than did patients who tested negative. Clinicians should be aware of the epidemi- ology of these pathogens in CAP.
Original language | English |
---|---|
Journal | Emerging Infectious Diseases |
Volume | 21 |
Issue number | 3 |
Pages (from-to) | 426-434 |
Number of pages | 9 |
ISSN | 1080-6040 |
DOIs | |
Publication status | Published - 01.01.2015 |
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)
DFG Research Classification Scheme
- 2.21-03 Medical Microbiology and Mycology, Hygiene, Molecular Infection Biology
- 2.21-05 Immunology
- 2.22-13 Pneumology, Thoracic Surgery
- 2.22-02 Public Health, Healthcare Research, Social and Occupational Medicine
- 2.22-31 Clinical Infectiology and Tropical Medicine